Skip to main content
SpringerLink
Log in

Isolated Familial Somatotropinoma

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The great majority of growth hormone (GH)-secreting pituitary tumors are sporadic, though a few occur with a familial aggregation, either as a component of multiple endocrine neoplasia, type 1 (MEN1) or Carney Complex, or when unassociated with other tumors, as isolated familial somatotropinomas (IFS). This report reviews the clinical and genetic information available from the 46 families reported to date with the latter syndrome. In contrast to sporadic tumors, GH-secreting tumors in IFS occur at an earlier age, especially when all affected family members are from a single generation. The IFS gene is believed to be a tumor suppressor gene, based on the presence of loss of heterozygosity. Although the gene still remains to be identified there is strong evidence for linkage to a locus of less than 10 Mb on chromosome 11q13.1–13.3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 1980;71–79.

  2. Etxabe J, Gaztambide P, Latorre P, Vazquez JA. Acromegaly: An epidemiological study. J Endocrinol Invest 1993;181–187.

  3. Gadelha MR, Kineman RD, Frohman LA. Familial somatotropinomas: Clinical and genetic aspects. Endocrinologist 1999;277–285.

  4. Schwoner J. Ueber hereditäre Akromegalie. Z Klin Med 1897;202–210.

  5. Fraenkel A, Stadelmann E, Benda C. Klinische und anatomische Beiträge zur Lehre von der Akromegalie. Dtsch med Wschr 1901;513–517, 536–539, 564–566.

    Google Scholar 

  6. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;363–371.

  7. Levin SR, Hofeldt FD, Becker N, Wilson CB, Seymour R, Forsham PH. Hypersomatotropism and acanthosis nigricans in two brothers. Arch Intern Med 1974;365–367.

  8. Kurisaka M, Takei Y, Tsubokawa T, Moriyasu N. Growth hormone-secreting pituitary adenoma in uniovular twin brothers. Neurosurgery 1981;226–230.

  9. Ananth J, Brown RD, Kravitz E. Familial manic depression, phenylketonuria and acromegaly. Can J Psychiatry 1982;258–260.

  10. Prescott RWG, Spruce BA, Kendall-Taylor P, Hall K, Hall R. Acromegaly and gigantism presenting in two brothers. 1st Joint Mtg Brit Endocr Soc 1982;49(Abstract).

  11. Jones MK, Evans PJ, Jones IR, Thomas JP. Familial acromegaly. Clin Endocrinol (Oxf) 1984;355–358.

  12. Abbassioun K, Fatourehchi V, Amirjamshidi A, Meibodi NA. Familial acromegaly with pituitary adenoma. Report of three affected siblings. J Neurosurg 1986;510–512.

  13. Pestell RG, Alford FP, Best JD. Familial acromegaly. Acta Endocrinol (Copenh) 1989;286–289.

  14. McCarthy MI, Noonan K, Wass JAH, Monson JP. Familial acromegaly: Studies in three families. Clin Endocrinol (Oxf) 1990;719–728.

  15. Tamburrano G, Jaffrain-Rea M-L, Grossi A, Lise A, Bulletta C. L’acromegalie familiale—A propos d’une observation. Revue de la litterature. Ann Endocrinol (Paris) 1992;201–207.

  16. Links TP, Monkelbaan JF, Dullaart RPF, van Haeften TW. Growth hormone-, alpha-subunit and thyrotrophin-cosecreting pituitary adenoma in familial setting of pituitary tumour. Acta Endocrinol (Copenh) 1993;516–518.

  17. Matsuno A, Teramoto A, Yamada S, Kitanaka S, Tanaka T, Sanno N, Osamura RY, Kirino T. Gigantism in sibling unrelated to multiple endocrine neoplasia: Case report. Neurosurgery 1994;952–956.

  18. Xu L, Ren Z, Su C. Surgical treatment of familial acromegaly. Chin J Surg 1995;435–436.

  19. Benlian P, Giraud S, Lahlou N, Roger M, Blin C, Holler C, Lenoir G, Sallandre J, Calender A, Turpin G. Familial acromegaly: a specific clinical entity - further evidence from the genetic study of a three-generation family. Eur J Endocrinol 1995;451–456.

  20. Kakiya S, Kawakubo A, Toyama K, Yamamoto M. Two cases of acromegaly in a family. Endocr J 1997;227–231.

  21. Tiulpakov A, Chistiakov DA, Strebkova NA, Tourakoulov RI, Peterkova VA, Nosikov VV. A case of familial acromegaly clinically unrelated to multiple endocrine neoplasia type 1: Investigation of the possible cause. Progr 79th Annu Mtg Endocr Soc 1997;P3–62(Abstract).

  22. Yamada S, Yoshimoto K, Sano T, Takada K, Itakura M, Usui M, Teramoto A. Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997;239–242.

  23. Stock JL, Warth MR, Teh BT, Coderre JA, Overdorf JH, Baumann G, Hintz RL, Hartman ML, Seizinger BR, Larsson C, Aronin N. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to multiple endocrine neoplasia type 1 locus at chromosome region 11q13. J Clin Endocrinol Metab 1997;486–492.

  24. Tanaka C, Yoshimoto K, Yamada S, Nishioka H, Setsuko II, Moritani M, Yamaoka T, Itakura M. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endocrinol Metab 1998;960–965.

  25. Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, et al. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998;2621–2626.

  26. Gadelha MR, Prezant TR, Une KN, Glick RP, Moskal SFI, Vaisman M, Melmed S, Kineman RD, Frohman LA. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type 1 gene. J Clin Endocrinol Metab 1999;249–256.

  27. Ackermann F, Krohn M, Windgassen M, Buchfelder M, Fahlbusch R, Paschke R. Acromegaly in a family without a mutation in the menin gene. Exp Clin Endocrinol Diab 1999;93–96.

  28. Verloes A, Stevenaert A, Teh BT, Petrossians P, Beckers A. Familial acromegaly: Case report and review of the literature. Pituitary 1999;273–277.

  29. Bergman L, Teh B, Cardinal J, Palmer J, Walters M, Shepherd J, Cameron D, Hayward N. Identification of MEN1 gene mutations in families with MEN1 and related disorders. Br J Cancer 2000;1009–1014.

  30. Ferretti E, Rea M-LJ, Asteria C, Di Stefano D, Esposito V, Ferrante L, Daniele P, Tiberti C, Gallucci M, Bosman C, Alesse E, Gulino A, Beck-Peccoz P, Tamburrano G. Two familial giant pituitary adenomas associated with overweight: Clinical, morphological and genetic features. Eur J Endocrinol 2001;227–235.

  31. Jorge BH, Agarwal SK, Lando VS, Salvatori R, Barbero RR, Abelin N, Levine MA, Marx SJ, Toledo SPA. Study of the multiple endocrine neoplasia type 1, growth hormone releasing hormone receptor, Gsα, and Gi2α genes in isolated familial acromegaly. J Clin Endocrinol Metab 2001;542–544.

  32. de Menis E, Prezant TR. Isolated familial somatotropinomas: Clinical features and analysis of the MEN1 gene. Pituitary 2001;11–15.

  33. Eguchi K, Gadelha MR, Kineman RD, Une KN, Teh BT, Frohman LA. Genetic studies in six families with isolated familial somatotropinoma: Strong evidence for linkage to chromosome 11q13. Progr 84th Annu Mtg Endocr Soc 2002;P3–633(Abstract).

  34. Tamura Y, Ishibashi S, Gotoda T, Yasufuku-Takano J, Takano K, Ueki K, Yamashita S, Iizuka Y, Yahagi N, Shionoiri F, Okazaki H, Ohashi K, Osuga J, Harada K, Shimano H, Fujita T, Yamada N, Kimura S. A kindred of familial acromegaly without evidence for linkage to MEN-1 locus. Endocr J 2002;425–431.

  35. Luccio-Camelo DC, Une KN, Ferreira RES, Khoo S-K, Nickolov R, Bronstein MD, Vaisman M, Teh BT, Frohman LA, Mendonca BB, Gadelha MR. A meiotic recombination in a new isolated familial somatotropinoma kindred. Eur J Endocrinol 2004;643–648.

  36. Lim YJ, Leem W, Kim TS, Rhee BA, Kim GK. Four years’ experience in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 1998;95-109.

  37. Fukuda I, Hizuka N, Murakami Y, Itoh E, Yasumoto K, Sata A, Takano K. Cinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women’s Medical University. Intern Med 2001;987–992.

  38. Abe T, Ludecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 2001;137–145.

  39. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A. Pituitary disease in MEN type 1 (MEN1). Data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;457–465.

  40. Baumann G, Maheshwari HG. The dwarfs of Sindh: Severe growth hormone (GH) deficiency caused by mutation in the GH-releasing receptor gene. Acta Pediatr 1997;33–38.

  41. Salvatori R, Hayashida CY, Aguiar-Oliveira MH, Phillips JA, III, Souza AH, Gondo RG, Toledo SPA, Conceicao MM, Prince M, Maheshwari HG, Baumann G, Levine MA. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 1999;917-923.

  42. Salvatori R, Thakker RV, Fan X, Eswara JR, Ellison D, Lees P, Harding B, Yang I, Levine MA. Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 2001;301–307.

  43. Lee EJ, Kotlar TJ, Ciric I, Lee MK, Lim SL, Lee HC, Huh KB, Mayo KE, Jameson JL. Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors. J Clin Endocrinol Metab 2001;3989–3995.

  44. Vallar L, Spada A, Giannattasio G. Altered G s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987;566–568.

  45. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of G s and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989;692–696.

  46. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppnes C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997;404–407.

  47. Gadelha MR, Une KN, Rhode K, Vaisman M, Kineman RD, Frohman LA. Isolated familial somatotropinomas: Establishment of linkage to chromosome 11q13.1–11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 2000;707–714.

  48. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlein A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. A high resolution recombination map of the human genome. Nat Genet 2002;241–247.

  49. Frohman LA, Eguchi K. Familial acromegaly. Growth Horm IGF Res 2004;S90–S96.

  50. Khoo S-K, Chan S-P, Pendek R, Jayaram M, Kanthimanti KS, Wong F-K, Motorna O, Valdes-Socin H, Frohman LA, Rea M-LJ, Tamburrano G, Beckers A, Teh BT. Clinical and genome-wide linkage studies of a multi-generational family with acromegaly and the exclusion of requiem gene. Progr 84th Annu Mtg Endocr Soc 2002;P1–680(Abstract).

  51. Gadelha MR, Rhode K, Kineman RD, Frohman LA. Isolated familial somatotropinomas: Does the disease map to 11q13 or to 2p16?—Authors’ response. J Clin Endocrinol Metab 2000;4921.

  52. Thakker RV, Pook MA, Wooding C, Boscoro M, Scanarini M, Clayton RN. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 1993;2815–2821.

  53. Tanaka C, Kimura T, Yang P, Moritani M, Yamaoka T, Yamada S, Sano T, Yoshimoto K, Itakura M. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab 1998;2631–2634.

  54. Prezant TR, Levine J, Melmed S. Molecular characterization of the Men1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab 1998;1388–1391.

  55. Une KN, Luccio-Camelo DC, Donangelo I, Feriera RES, Alegria AR, Vaisman M, Filho PN, Marcondes J, Kineman RD, Frohman LA, Gadelha MR. Loss of heterozygosity (LOH) at chromosome 11q13 in sporadic somatotropinomas and correlation with aggressive behavior. Progr 84th Annu Mtg Endocr Soc 2002;P3–624(Abstract).

Download references

Author information

Authors and Affiliations

  1. Section of Endocrinology and Metabolism, University of Illinois at Chicago, 60612, IL

    Beatriz Santana Soares & Lawrence A. Frohman

  2. Section of Endocrinology and Metabolism (MC 640), University of Illinois at Chicago, 1819 W Polk Street, Illinois, 60612, Chicago, USA

    Lawrence A. Frohman

Authors
  1. Beatriz Santana Soares
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence A. Frohman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence A. Frohman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soares, B.S., Frohman, L.A. Isolated Familial Somatotropinoma. Pituitary 7, 95–101 (2004). https://doi.org/10.1007/s11102-005-0-04-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-005-0-04-0

Key Words

Search

Navigation